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ABSTRACT
RbpA is a small non–DNA-binding transcription
factor that associates with RNA polymerase
holoenzyme and stimulates transcription in
actinobacteria, including Streptomyces coelicolor
and Mycobacterium tuberculosis. RbpA seems to
show specificity for the vegetative form of RNA
polymerase as opposed to alternative forms of the
enzyme. Here, we explain the basis of this specifi-
city by showing that RbpA binds directly to the prin-
cipal p subunit in these organisms, but not to more
diverged alternative p factors. Nuclear magnetic
resonance spectroscopy revealed that, although
differing in their requirement for structural zinc,
the RbpA orthologues from S. coelicolor and
M. tuberculosis share a common structural core
domain, with extensive, apparently disordered, N-
and C-terminal regions. The RbpA–p interaction is
mediated by the C-terminal region of RbpA and p
domain 2, and S. coelicolor RbpA mutants that are
defective in binding p are unable to stimulate tran-
scription in vitro and are inactive in vivo. Given that
RbpA is essential in M. tuberculosis and critical for
growth in S. coelicolor, these data support a model
in which RbpA plays a key role in the p cycle in
actinobacteria.
INTRODUCTION
The high G+C, Gram-positive actinobacteria are of
immense medical and industrial importance. For
example, although the Streptomyces genus is a key
source of bioactive compounds, including antibiotics, im-
munosuppressants and anti-cancer drugs, Mycobacterium
tuberculosis has maintained its global notoriety, currently
causing 9 million cases and 1.5 million tuberculosis deaths
per year (1). As well as being a major target for anti-myco-
bacterial agents, such as rifampicin, RNA polymerase
(RNAP) also has a major inﬂuence on the control of anti-
biotic biosynthesis in Streptomyces, and mutations in this
enzyme complex can both positively and negatively impact
production (2,3). Therefore, a deeper understanding of
RNAP and its regulation in the Actinobacteria phylum
can contribute to both the production and development
of new medicines.
Transcription initiation in bacteria occurs in several
steps. First, an RNAP holoenzyme binds to a promoter
element to form an initial closed complex in which the
DNA remains double-stranded. This triggers a process
of isomerization in which the DNA unwinds, and
localized DNA melting reveals the template strand to
the active site of the enzyme, giving rise to an open
complex. Subsequently, short abortive transcripts are
produced in a cyclical manner before the RNAP escapes
into the elongation phase (4). The RNAP holoenzyme can
be divided into core (ﬁve subunits, 2a, b, b0 and o), which
is catalytically active for elongation, and a dissociable s
factor subunit that is required for promoter recognition.
The s subunit provides critical DNA-binding determin-
ants in both closed and open complexes, but it stochastic-
ally dissociates from elongating RNAP soon after
promoter escape (5,6). This scheme gives rise to a ‘s
cycle’ whereby the dissociated s factor enters a pool of
s factors that compete for binding to core RNAP (7).
Bacteria are, therefore, able to tune gene expression by
controlling the cellular level and composition of s
factors (8). All bacteria seem to contain a single essential
s factor that is orthologous to s70 of Escherichia coli and
directs the transcription of most ‘housekeeping’ genes
during exponential growth, such as those involved in
ribosome production and central metabolism. Structural
studies on the principal s factors of E. coli and Thermus
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sp., either alone or in the context of holoenzyme, revealed
four domains, s1.1, s2, s3 and s4, that are interconnected
by ﬂexible linkers and correspond to conserved regions
1.1, 1.2–2.4, 3.0–3.1 and 4.1–4.2, respectively (9–12). The
s2, s3 and s4 domains each comprise key contact points
for both core enzyme and promoter DNA, whereas s1.1 is
thought to maintain free s in a compact non–DNA-
binding form through interaction with s2 and s4 (12).
In addition to a principal and essential s factor,
bacteria usually contain one or more alternative s
factors that can redirect the transcription machinery to
speciﬁc regulons, allowing the cell to respond to a wide
variety of environmental, physiological or developmental
cues (8). Most of these are related to s70 and have been
classiﬁed into four main groups (Groups 1–4) based on
phylogeny and biological function (13): Group 1 s factors
are the s70 orthologues; Group 2 s factors are closely
related to Group 1 s factors but have specialized non-
essential functions; Group 3 s factors are structurally
and functionally diverse but include all three globular
domains (s2–s4); Group 4 comprises the highly diverse
extracytoplasmic function (ECF) s factors that lack
both Region 1 and the s3 globular domain. The control
of alternative s factor activity is particularly well estab-
lished and often occurs at the post-translational level
through the action of anti-s factors that bind to s and
prevent its association with core RNAP (14). The s factor
is released after the inactivation of the anti-s factor
through competition with an alternative binding partner
(partner-switching), regulated proteolysis or an allosteric
change in response to the direct sensing of a signal.
Although the s subunit can act as an essential contact
point for DNA-binding activators, proteins that bind to
and activate free s factors are rare. One example,
however, is the small protein Crl, which stimulates the
activity of the stationary phase regulator sS in E. coli
and Salmonella (15) through direct interaction, both
with free s and as part of the holoenzyme (16,17). The
role of Crl seems to be to improve the association of sS
with core RNAP through interaction with the s2 globular
domain (18–21).
RbpA is an RNAP-binding protein that is conﬁned to,
and widespread within, the actinobacteria, and evidence is
accumulating that it plays a crucial role in transcription
initiation. RbpA was discovered in the antibiotic-
producing bacterium Streptomyces coelicolor where the
124 amino acid protein was shown to confer basal levels
of resistance to rifampicin in vivo and stimulate transcrip-
tion in vitro (22,23). The S. coelicolor RbpA (designated
RbpASc for clarity) co-puriﬁes as a major component of
RNAP holoenzyme, suggesting a broad role in transcrip-
tion, although stimulation of transcription was previously
only demonstrated using the ribosomal RNA promoter
rrnDp3 (22). The rrnDp3 promoter is dependent on the
principal s factor in S. coelicolor, sHrdB, and RbpASc
failed to stimulate transcription from a promoter depend-
ent on the alternative s factor sR (22). Although
S. coelicolor mutants that lack RbpASc grow slowly,
they are viable. However, it was recently demonstrated
that RbpA (Rv2050; designated RbpAMt for clarity) is
essential in M. tuberculosis (24). Furthermore, RbpAMt
was shown to stabilize the principal sA-RNAP holoen-
zyme and stimulate transcription from wide range of sA-
dependent promoters in vitro, suggesting a general role in
transcription initiation (25). Two biochemical studies have
proposed that the primary contact point for RbpAMt is
the b subunit. However, although one study proposed
binding close to the active-site cleft near the rifampicin-
binding site (26), the other study proposed that RbpAMt
contacts the sandwich-barrel hybrid motif located on the
surface of the b subunit (25). In either study, the apparent
speciﬁcity of RbpAMt for the principal s factor was not
explained, although it was proposed that RbpAMt might
allosterically modify core RNAP to improve its inter-
action with s (25). Here, we show that RbpA binds spe-
ciﬁcally to the principal and certain related s factors of
S. coelicolor and M. tuberculosis, and that RbpASc is
present at a sHrdB–RNAP transcription initiation
complex in vivo. The orthologous RbpA proteins from
these organisms comprise a core domain, for which we
present the high-resolution solution structures, together
with extensive N- and C-terminal regions that are dis-
ordered in the free proteins. Finally, we map the inter-
action between S. coelicolor sHrdB and RbpASc, and we
show that binding occurs primarily between the s2
domain of sHrdB and the C-terminal region of RbpASc.
Our data support a model in which RbpA plays a key role
in the s cycle of the vegetative RNAP in actinobacteria,
possibly acting as a chaperone-like protein to aid the
formation of active holoenzyme, which might be particu-
larly important during stress.
MATERIALS AND METHODS
Strains, plasmids and growth conditions
Strains and plasmids are listed in Supplementary Table S1,
and oligonucleotides used for the construction of plasmids
are listed in Supplementary Table S2. E. coli K-12 strain
DH5a was used for general cloning and plasmid propaga-
tion, and E. coli ET12567 (pUZ8002) was used to conju-
gate plasmids into S. coelicolor (27). S. coelicolor A3(2)
strains were cultivated on mannitol–soya (MS) agar or in
a modiﬁed yeast extract–malt extract (YEME, 10%
sucrose and 0.01% antifoam) broth as previously
described (27). To construct S. coelicolor S129, a
rbpA::apr allele was introduced into the S. coelicolor
J1981 (rpoC-His6) genome by double crossover recombin-
ation as described previously (22). To construct pSX190,
the S. coelicolor rbpA gene and promoter region were
ampliﬁed using oligonucleotide primers rbpA_H3_rev
and DT1a (22), thereby introducing a HindIII site imme-
diately upstream of the stop codon, then fused to a triple
FLAG tag sequence in the integrative vector pSET152.
Site-directed mutagenesis of the C-terminal region of
rbpA was performed in pSX512, and the rbpA derivatives
were cloned along with the native promoter into pSET
as a BglII fragment.
Protein overexpression and puriﬁcation
Core RNAP was prepared from late-exponential
YEME cultures of S. coelicolor S129. Harvested
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mycelium was re-suspended in binding buffer (20mM
Tris–HCl, pH 7.5, 500mM NaCl, 20mM imidazole,
3mM 2-mercaptethanol, 5% glycerol and 25 mg/ml
phenylmethanesulphonyl ﬂuoride) plus complete
ethylenediaminetetraacetic acid (EDTA)-free protease in-
hibitor (Roche). Mycelium was lysed by passing twice
through a French press at 10 000 kPa before centrifugation
to remove the cell debris. The lysate was immediately
loaded on a Ni-IDA sepharose column and washed with
10 column volumes of binding buffer followed by 5
column volumes buffer A (20mM Tris–HCl, pH 7.5,
3mM 2-mercaptoethanol, 5% glycerol and 150mM
NaCl) containing 20mM imidazole, then eluted with
buffer A containing 250mM imidazole. The eluate was
immediately applied to a HiTrap Heparin HP column
(GE Healthcare) equilibrated with buffer A, and protein
was eluted from the column using a salt gradient (20mM
Tris–HCl, pH 7.5, 3mM 2-mercaptoethanol, 5% glycerol
and 1M NaCl). RNAP fractions were dialysed against
buffer C (20mM Tris–HCl, pH 7.5, 3mM
2-mercaptoethanol, 5% glycerol and 50mM NaCl) and
further puriﬁed by mono-Q (GE Healthcare) ion-
exchange chromatography. Core-rich RNAP fractions
were eluted in tail fractions from the mono-Q column.
Native RbpASc, hexahistidine (His6)-tagged RbpA
Sc and
sHrdB were prepared as described previously (22). For
in vitro transcription reactions, the His6-tag on RbpA
Sc
was removed by treatment with thrombin, and the
protein was puriﬁed by gel ﬁltration. For expression of
truncated sHrdB domain fragments (s2, s2–s4, s3–s4
and s4) with N-terminal His6-tags, polymerase chain
reaction (PCR) was used to amplify the corresponding
hrdB regions with primers incorporating N-terminal
NdeI and C-terminal XbaI sites and cloned into
pET15b. Expression was achieved in E. coli BL21DE3
(pLysS), and fragments were puriﬁed using Ni-NTA spin
columns (Qiagen) as recommended by the manufacturer.
For NMR analysis, the full-length M. tuberculosis rbpA
gene (Rv2050) was ampliﬁed by PCR incorporating an
N-terminal NdeI site and C-terminal BamHI site and
cloned into pET20b to give pSX500. To solve the structure
of the core domain of RbpASc, a truncated gene encoding
the ﬁrst 75 amino acids was chemically synthesized with
codon optimization (Euroﬁns) for expression in E. coli
and subsequently cloned into pET15b to give pSX505.
E. coli BL21DE3 (pLysS) containing pSX500 or
pSX505 was grown in L-broth to OD600 of 3–5, then
transferred to optimized high-cell density isopropyl-b-D-
thiogalactopyranoside (IPTG)-induction minimal media
(28,29) containing 0.1% 15NH4Cl and 1%
13C-glucose,
grown for 2 h at 37C, before induction with 1mM
IPTG at 30C for 3 h. Oligonucleotides used to amplify
each gene or domain are listed in Supplementary Table S2.
In vitro transcription reactions
In vitro transcription assays were carried out using
S. coelicolor S129 core RNAP and puriﬁed native sHrdB
and RbpASc proteins, essentially as described previously
(30). Templates containing promoters were ampliﬁed by
PCR using primers listed in Supplementary Table S2.
Assays (10ml) were performed at 30C, and they contained
5 nM DNA template in reaction buffer (50mM Tris–HCl,
pH 8, 10mM MgCl2, 200mM KCl, 0.1mg/ml of bovine
serum albumin and 10mM b-mecaptoethanol). sHrdB,
RbpASc and core RNAP were mixed in RNAP dilution
buffer (10mM Tris–HCl, pH 8, 10mM KCl, 0.4mg/ml of
bovine serum albumin, 0.1mM Na2EDTA, 0.1% Triton
X-100 and 10mM b-mecaptoethanol) (30) for 15min on
ice, and reactions were initiated by the addition of nucleo-
tide mix (1mM adenosine triphosphate, GTP, CTP and
50 mMUTP), including 5 mCi [a-32P] UTP (>800Ci/mmol,
GE Healthcare), and incubated for 15min. Reactions were
halted by addition of an equal volume of in vitro loading
dye [80% (w/v) formamide, 0.01% (w/v) xylene cyanol
and 0.01% (w/v) bromophenol blue], separated on
denaturing 6% polyacrylamide gels and quantiﬁed by
phosphorimaging.
Bacterial two-hybrid analysis
The complete rbpA genes from S. coelicolor and M. tuber-
culosis, as well as truncated derivatives as indicated in
ﬁgure legends, were PCR ampliﬁed then cloned into
pUT18, generating rbpA-T18 translational fusions to the
T18 catalytic domain of Bordetella pertussis adenylate
cyclase. The s factor genes from S. coelicolor (hrdA,
hrdB, hrdC, hrdD, sigB, sigE, sigR and whiG) and M. tu-
berculosis (sigA and sigB), as well as truncated derivatives
of hrdB, were cloned into pKT25, generating T25-s trans-
lational fusions to the T25 catalytic domain. The amino
acids included in each truncated hybrid construct are
indicated in the ﬁgure legends, and the oligonucleotides
used for PCR ampliﬁcation are indicated in
Supplementary Table S2. Functional complementation
between chimeric proteins was evaluated in E. coli
BTH101 by performing b-galactosidase measurements
on permeabilized overnight cultures grown in L-broth
containing 0.5mM IPTG. One unit of b-galactosidase
activity corresponds to 1 nmol of o-nitrophenyl-b-D-
galactoside (ONPG) hydrolysed per min at 28C.
Results were presented either as Miller units (31) or as
% Miller units relative to a control.
In vitro pull-down assays
Experiments were performed using Dynabeads His-Tag
Isolation and Pulldown beads (Invitrogen) essentially as
recommended by the manufacturer. Test proteins were
mixed on ice in binding buffer (50mM sodium phosphate,
pH 8, 300mMNaCl and 0.01% Tween-20), then added to
20ml magnetic Dynabeads and left to incubate for 30min at
ambient temperature with shaking. Samples were washed
four times, and then eluted in 100ml elution buffer (binding
buffer plus 300mM imidazole) for 15min.
Chromatin immunoprecipitation–quantitativePCR
Strains were grown in modiﬁed YEME to mid-late expo-
nential phase (OD450: 2.0), treated with rifampicin
(140mg/ml) for 20min, then formaldehyde [1.1% (v/v);
Sigma] for a further 20min, with continued shaking at
200 rpm. After quenching with 0.5M glycine for 5min at
30C, mycelium was collected by centrifugation, washed
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twice in phosphate-buffered saline and stored at 20C.
Chromatin extraction and immunoprecipitation protocols
were essentially as described previously (32). Mycelial
pellets were subjected to 3 90 s of cryogenic grinding
(Retsch MM301, 30Hz) then resuspended in 9ml of IP
buffer (32), and 3-ml aliquots were sonicated (35% amp-
litude) for 4, 8 and 12 cycles of 15 s ON and 45 s OFF.
After clearing by centrifugation, 70 ml of samples were
incubated with proteinase K (Roche), de-cross-linked
and then analysed by gel electrophoresis (32). Samples
comprising chromatin fragments of 0.5 kb were pre-
cleared by incubation (rotation for 4 h at 4C) with
either protein A or protein G magnetic beads (NEB)
before the addition of antibodies. Immunoprecipitations
were conducted with M2 mouse monoclonal anti-FLAG
antibody (Sigma), monoclonal 8RB13 anti-E. coli RNAP
b subunit antibody (Abcam) or a custom rabbit polyclonal
antiserum raised against sHrdB (Eurogentec).
Corresponding mock immunoprecipitations (IPs) with
no added antibody were performed as negative control.
After incubation with antibodies (rotation for 12 h at
4C), immunoprecipitations were performed using
protein G magnetic beads (RbpASc and RNAP; NEB)
or protein A magnetic beads (sHrdB; NEB). Subsequent
steps to dissociate cross-links and purify DNA were as
described previously (32), and DNA was resuspended in
25 ml of ultrapure water. Quantitative real-time PCR was
performed using the standard curve absolute quantiﬁca-
tion approach using serial dilutions of sonicated S.
coelicolor M145 genomic DNA to generate standard
curves for each of the four primer pairs used
(Supplementary Table S2). qPCR reactions were set-up
in 0.1ml of MicroAMP FAST optical 96-well reaction
plates (Applied Biosystems) using GoTaq qPCR reaction
mix (Promega), 10 ng of template DNA and each primer
at 0.15 pmol/ml. The data were analysed using a modiﬁed
method to that previously described (33). The mock
immunoprecipitation (IP) signal was subtracted from the
signal obtained using the corresponding immunopre-
cipitated sample DNA as input to correct for background
signal. To allow visual comparison of the relative enrich-
ments obtained using the three different antibodies, the
background corrected signals obtained using a particular
antibody were expressed relative to the highest corrected
signal obtained using either of the four primer pairs.
Metal analysis
Native (un-tagged) RbpA proteins were produced in E. coli
and puriﬁed by ion-exchange chromatography and gel ﬁltra-
tion, before concentration as described previously (22).
Approximately 0.5mg of protein was vacuum-dried then
re-suspended in 86ml of 70% nitric acid (metal analysis
grade) and heated for 10min at 105C. Water (metal
analysis grade) was added to give a ﬁnal concentration of
2% nitric acid, and inductively coupled plasma mass spec-
trometry was performed using an Agilent 7500 series instru-
ment. A solution containing 1ppm of each metal to be
analysed (Mn, Fe, Ni, Cu and Zn) was used as standard,
and values were normalized against protein storage buffer
alone. Experiments were performed in duplicate.
NMR and solution structure determination
Samples were buffer-exchanged into 100 mMMES buffer,
pH 6.0, with 150mM KCl. NMR experiments were
performed on >200 mM samples of uniformly 15N- and
13C-labelled protein.
The backbone resonance assignments of RbpASc and
RbpAMt were completed by using the standard triple-res-
onance assignment approach (34), and data were analysed
using in-house algorithms with the program NMRView
(35). Ha and Hb assignments were obtained using
HBHA(CBCACO)NH. The side-chain assignments of the
two proteins were extended using HCCH TOCSY and
(H)CC(CO)NH TOCSY. The distance restraints were
obtained from 1H-15N/13C nuclear Overhauser effect spec-
troscopy (NOESY)–heteronuclear single- or multiple-
quantum coherence (HSQC/HMQC) experiments (mixing
time, 100ms at 800MHz). Data were collected on Bruker
AvanceIII (600MHz) and AvanceII (800MHz) spectrom-
eters equipped with TCI and TXI cryoprobes, respectively.
The ARIA protocol was used for completion of the NOE
assignment and structure calculation (36). Dihedral angle
restraints derived from TALOS were also incorporated in
the calculation (37). The frequency window tolerances for
assigning NOEs were ±0.05 ppm for direct proton dimen-
sions and ±0.05 ppm for indirect proton dimensions, and
±0.5 ppm for nitrogen dimensions and ±1.3 ppm for
carbon dimensions. One hundred structures were
calculated in the ﬁnal iteration, and these had no NOE
violations >0.5 A˚ and no dihedral angle violations >5.
The 10 lowest energy structures were selected for further
analysis and ﬁgure generation.
RESULTS
RbpASc activates a range of pHrdB-dependent promoters
Previously, using total RNAP holoenzyme preparations,
we showed that RbpASc stimulated transcription in vitro
from the sHrdB-dependent promoter rrnDp3, but not from
a sR-dependent promoter, rbpAp (22). Initially, we
extended this work by showing that RbpA increased the
maximal activity of sHrdB–RNAP at the rrnDp3 promoter
by titrating increasing concentrations of sHrdB in the
presence and absence of excess RbpASc (Figure 1A). We
then tested whether the RbpASc activity was speciﬁc to
rrnDp3 or whether it played a more general role in
activating sHrdB-dependent promoters. Transcription
run-off assays were performed with a selection of pro-
moters that we or others have predicted to be dependent
on sHrdB, based on the putative 10 promoter elements:
sacAp (38), tuf3p (39), relAp2 (40), atpIp (unpublished ob-
servations) and rplJp (41). In each case, RbpASc
stimulated transcription in assays consisting of core
RNAP, sHrdB and linear DNA templates (Figure 1B).
RbpASc also activated transcription initiation in single-
round transcription assays, which suggests that the stimu-
latory effect is not a consequence of increased recycling or
elongation (data not shown). Together with the previous
demonstration that RbpAMt stimulates a range of sA-
dependent promoters with no apparent speciﬁcity (25),
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these data support the idea that RbpA is a general activa-
tor of the principal RNAP holoenzyme in actinobacteria.
Although it is known that RbpASc is present in puriﬁed
RNAP preparations, it has not yet been shown to be
present in RNAP–promoter complexes in vivo. We,
therefore, decided to test this using chromatin
immunoprecipitation combined with quantitative PCR
(ChIP–qPCR). The presence of RbpASc, sHrdB and the
b subunit of RNAP was analysed at the rplJp promoter.
Immunoprecipitation of b and sHrdB was performed using
a commercially available monoclonal antibody (42) and a
polyclonal antibody, respectively. To immunoprecipitate
RbpASc, the rbpA gene was C-terminally tagged with
tandem FLAG epitopes and integrated into the genome
of the S. coelicolor rbpA mutant S129 at the fC31 attach-
ment site using the vector pSET152. The resulting con-
struct, pSX190, fully restored normal growth rate to
S129, indicating that that the epitope tag did not impede
normal RbpASc function (data not shown). S. coelicolor
S129 (pSX190) was grown to mid-exponential phase
before treatment with rifampicin to inhibit global RNA
synthesis by trapping RNAP at promoters (43). As
expected, the rplJ promoter region (qPCR product 2;
Figure 2), centred 79 bp upstream from the transcription
start point, was highly enriched for both sHrdB and the b
subunit, with much lower enrichment seen for control
regions centred 653 bp upstream, or +235 bp and
+608 bp downstream, of the transcription initiation site,
suggesting that sHrdB–RNAP was indeed trapped at the
rplJ promoter (Figure 2). The enrichment patterns seen
using the anti-FLAG antibody were similar to those
obtained with the sHrdB and the b antibodies, indicating
that RbpASc is present in these transcription initiation
complexes, although it should be noted that differences
in antibody–epitope afﬁnities prevent the relative propor-
tion of initiation complexes that contain RbpASc from
being assessed. Control anti-FLAG immunoprecipitation
experiments using an equivalent strain in which RbpASc
was untagged showed no enrichment above that seen with
the ‘no antibody’ control, conﬁrming that this signal is
speciﬁc to RbpASc (data not shown).
RbpA binds speciﬁcally to principal and related p factors
We considered the possibility that the apparent speciﬁcity
of RbpA activity towards promoters recognized by the
principal s factors might be determined by a direct inter-
action with the s factor itself. To test this idea, we applied
Figure 1. RbpASc activates transcription from a range of sHrdB-
dependent promoters in vitro. (A) Multi-round in vitro transcription
reactions using the rrnDp3 promoter as template (22) and including
core RNAP (75 nM) sHrdB at sHrdB: RNAP ratios of 0, 0.5, 1, 1.5
or 2, or 3, in the presence (grey bars) or absence (black bars) of
excess RbpASc (40 mM). rrnDp3 transcription products are normalized
relative to the highest signal. Note that these preparations of core
RNAP have residual levels of sHrdB. (B) Multi-round in vitro transcrip-
tion reactions contained core RNAP (75 nM) sHrdB (375 nM), RbpASc
(750 nM) and DNA templates generated by PCR using primers listed in
Supplementary Table S2. Data are presented as fold-difference relative
to reactions lacking RbpA. Transcript levels were quantiﬁed by
phosphorimaging from triplicate data, and standard deviation is
indicated.
Figure 2. Localization of RbpASc at a sHrdB-dependent promoter
in vivo. (A) Schematic of the rplJ region. The transcription start
point (+1) of rplJp is indicated by a black arrow located 240 bp
upstream from the rplJ start codon. The bars above the genes show
the relative positions of PCR products used for ChIP–qPCR that are
centred with respect to +1 as follows: 1, 653 bp; 2, 79 bp; 3,
+235 bp; 4, +235 bp. (B) Occupancy of RbpASc, RNAP b subunit,
and sHrdB at the indicated regions in S. coelicolor S129 (pSX190),
after treatment with rifampicin. Immunoprecipitations were performed
using monoclonal anti-b, polyclonal anti-sHrdB and anti-FLAG
antibody to detect RbpA–FLAG. To allow comparison of RbpASc,
b and sHrdB localization, after absolute quantitation of co-immunopre-
cipitated DNA and background correction for each antibody, enrich-
ment is presented relative to the highest corrected signal obtained using
either of the four primer pairs. Standard deviations (calculated for two
biological replicates) are indicated.
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a bacterial two-hybrid (BACTH) assay based on the
B. pertussis adenylate cyclase (44). The S. coelicolor rbpA
gene was fused to the gene that encodes the T18 domain of
adenylate cyclase such that RbpASc was at the N-terminus
of the fusion protein. A range of s factor genes were fused
to the gene that encodes the T25 domain, such that the s
factors were located at the C-terminus of the fusion
proteins. Initially we tested for interaction between
RbpASc and the following S. coelicolor s factors: sHrdB
(Group 1); sHrdA, sHrdC and sHrdD (Group 2); sWhiG
and sB (Group 3); and sE and sR (Group 4)
(Figure 3A). The Group 1 and Group 2 s factors were
N-terminally truncated such that they included only
conserved regions 1.2–4.2, which comprise structural
domains s2, s3 and s4. This was necessary because full-
length T25–hrdB fusions seemed to be toxic to E. coli.
A positive result was detected for sHrdB and sHrdA,
whereas none of the remaining s factors bound to
RbpASc. This suggests that RbpASc interacts only with
principal and closely related s factors. To broaden this
idea, we tested for interaction between RbpAMt and
M. tuberculosis s factors sA (Group 1) and sB (Group
2). Binding was detected in both cases (Figure 3A), which
suggests that the interaction with principal and related s
factors is a general feature of RbpA proteins in
actinobacteria. In principal, the interactions observed
during in vivo two-hybrid analysis could involve E. coli
RNAP in hybrid higher order complexes. To conﬁrm
that the interaction between RbpASc and sHrdB does not
involve any other factors, the two proteins were analysed,
separately or mixed, by gel ﬁltration chromatography
(Figure 3B). sHrdB (55.9 kDa) and RbpASc (14.1 kDa)
eluted at different volumes with apparent molecular
masses of 183.2 and 29.9 kDa, respectively, suggesting
trimeric and dimeric complexes. When mixed together, a
complex of the two proteins eluted close to the sHrdB peak
with an apparent mass of 211.4 kDa. Although it is clear
that the two proteins interact, the difference in size between
sHrdB and RbpASc, and our suspicion that sHrdB might run
anomalously during gel ﬁltration, makes it difﬁcult to
predict precise stoichiometry at this point.
RbpA orthologues differ in their zinc content
Protein sequence alignments suggested that the RbpA
orthologues from S. coelicolor and M. tuberculosis might
differ in their metal content (Figure 4). S. coelicolor
RbpASc contains three cysteine residues, Cys35, Cys56
and Cys59, and a histidine His38, each of which are
widely conserved (e.g. in Biﬁdobacterium sp. and Frankia
sp.) and arranged as a putative C(H/C)CC zinc-ribbon
motif. Surprisingly, RbpAMt, along with RbpA ortho-
logues from Corynebacterium sp. and Nocardia sp., lacks
all of these residues apart from the Cys56-equivalent
cysteine. To investigate metal content, we isolated
RbpASc and RbpAMt from overproducing E. coli strains
in their native (untagged) forms. Inductively coupled
plasma mass spectrometry (ICP-MS), set to detect Mn,
Fe, Ni, Cu and Zn, revealed zinc as the only metal
present at signiﬁcant quantities in RbpASc, at a stoichiom-
etry of 0. 83 (±0.04) mol zinc mol1 protein. Conversely,
no metal was detected at signiﬁcant levels in RbpAMt.
To test the importance of the presumed cysteine zinc
ligands in RbpASc, each was mutated to alanine, and the
resultant genes were introduced into S. coelicolor S101
(rbpA::hyg) using the integrative expression vector
pIJ6902 to test for complementation. In each case, the
mutant genes failed to restore normal growth rate
(Supplementary Figure S1), suggesting that each residue
is crucial for the function or stability of the protein. Each
Figure 3. RbpA binds to the principal and closely related s factors.
(A) BACTH analysis of RbpA from S. coelicolor (RbpASc) and M.
tuberculosis (RbpAMt) interactions with s factors from S. coelicolor
(Group 1, sHrdB; Group 2, sHrdA, sHrdC and sHrdD; Group 3, sHrdB
and sWhiG; Group 4, sE and sR) and M. tuberculosis (Group 1, sA;
Group 2, sB). The rbpA genes were fused to the T18 subunit of B.
pertussis adenylate cyclase, whereas the s factor genes were fused to the
T25 subunit. Groups 1 and 2 s factor hybrid fusions included only s
domains s2, s3 and s4, whereas the remaining s factor fusions were
full length. b-galactosidase assays were performed in triplicate, and
standard deviations are indicated. Control strains contained C1,
pUT18-rbpASc, pKT25; C2, pUT18-rbpAMt, pKT25. (B) Co-elution of
RbpASc and sHrdB during size-exclusion chromatography. (i) sHrdB
(5 nmol), (ii) RbpASc (5 nmol) or a mixture of the two (iii) were
passed through a Superose 6 10/300 GL size-exclusion column, and
1ml of fractions (indicated by numbers) were separated by sodium
dodecyl sulphate–polyacrylamide gel electrophoresis (SDS–PAGE)
and silver stained.
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of the three histidine residues in RbpASc was also changed
to alanine, although in each case the mutant protein com-
plemented the S101 strain (Supplementary Figure S1),
suggesting that the protein retains function even when
the functional requirement of zinc is conferred solely by
the cysteine ligands.
The solution structure of the core domain of RbpA from
M. tuberculosis and S. coelicolor
To investigate why RbpASc and RbpAMt differ in their
zinc content and to dissect the structure–function relation-
ship of RbpA, we used NMR spectroscopy to determine
the solution structure of each protein. The dispersion of
resonances in proton NMR spectra recorded on both
RbpA proteins clearly showed that the proteins were at
least partially structured (data not shown), although the
M. tuberculosis protein gave better spectra and was, there-
fore, our initial focus. To determine the structured
portions of the protein, attempts were made to assign
backbone amides. Despite efforts to prevent proteolysis,
the samples degraded rapidly, and complete assignments
were obtained only for the core domain. Resonance line
widths and chemical shift dispersion indicate that regions
outside these domains are highly disordered. The solution
structure of the core domain was then determined using
standard multidimensional NMR spectroscopy methods.
After this, we determined the structure of the RbpASc core
domain using a truncated clone that included RbpASc
residues 1–75. The structures of the RbpA orthologues
(Figure 5; see Supplementary Table S3 for NMR and re-
ﬁnement statistics) reveal a compact core domain (residues
28–72; designated the RbpA core domain, RCD)
comprising four b strands that form a partially open b
barrel. Residues 29–34, 37–43, 53–56 and 62–67 make
up strands b1, b2, b3 and b4, respectively. In RbpASc,
the three Cys residues cluster together with His38 to
form the likely metal-binding site, which is, together
with the presence of Zn, consistent with a CHCC Zn-
ribbon fold, a major subclass of the zinc-ﬁnger family,
particularly common in proteins involved in translation
and transcription (45). In RbpAMt, in place of the key
residues (Cys34, His38, Cys56 and Cys59) are the follow-
ing conserved hydrophilic residues: Thr34, Glu38, Cys56
and Asn58, which form a stabilizing hydrogen bond
network (Figure 5E and F). Interestingly, although the
RCD domain of RbpASc is largely negatively charged,
the ﬂexible N-terminal tail (1–26) is positively charged
(Figure 5G), which may implicate this region in an inter-
action with DNA in transcription initiation complexes.
Although the classical zinc-ﬁnger structure in the
RbpASc RCD may suggest that it is specialized for
DNA binding, the electrostatic potential and the absence
of the Zn binding in other orthologues suggest that it is
primarily a structural scaffold. The b-barrel structure is
seen in other proteins (Supplementary Figure S2),
including domains from mini-chromosome maintenance
complexes (46), ribosomal protein L27 (47) and polypep-
tide chain release factors (48). Although the precise role
of this domain in these proteins is unclear, they, along
with adjacent sequences, seem to contribute to stabilizing
either protein–protein or protein–RNA interactions.
Interestingly, for example, the ribosomal protein L27
has a disordered N-terminal region (residues 1–19) in the
oligonucleotide-free form, but in complex it forms an
extended structure and interacts with the acceptor stem
of the P-site tRNA and contributes to an increase in
catalysis (49).
The C-terminal region of RbpASc is required for
interaction with pHrdB
Although the NMR structures of the RbpA core domain
did not include the C-terminal region, and indeed sug-
gested that this region was disordered, sequence-based
structural predictions using the Phyre 2 package (50)
suggested the presence of two a-helices (designated a1
and a2), the second of which would be particularly amphi-
pathic with a negatively charged face (Figure 4).
To identify the region of RbpASc that interacts with
sHrdB, we used BACTH to test three truncated
S. coelicolor rbpA-T18 fusions for interaction with
Figure 4. Alignment of the amino acid sequences of selected RbpA orthologues. STRCO, S. coelicolor, NP_625703; FRASC, Frankia sp. CcI3,
YP_481367; NOCFA, Nocardia farcinica, YP_119325; M. tuberculosis H37Rv, NP_216566. Residues that coordinate a zinc atom in RbpASc, or form
a stabilizing hydrogen bonding network in RbpAMt, are indicated with black dots. Arginine residues that when mutated prevent sHrdB interaction are
indicated by grey dots (Figure 6). The b-strand secondary structure elements in the RCD domain are indicated, as are predicted a-helices in the
C-terminal region.
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T25-sHrdB (Figure 6): RbpASc lacking both predicted C-
terminal helices (residues 1–72, RbpA1-72); RbpASc
lacking only a2 (RbpA1-90); and RbpASc lacking the
N-terminal region and RCD domain but including a1
and a2 (RbpA73124). In contrast to RbpA172 and
RbpA190 for which an interaction with sHrdB was not
detected, RbpA73124 did interact, indicating that the
C-terminal helical region of RbpASc is necessary and suf-
ﬁcient for binding. To identify critical residues involved in
this interaction, we performed alanine-scanning mutagen-
esis, focusing on highly conserved residues in the C-
terminal region. Apparent binding effects were observed
for the highly conserved ERR motif (amino acid residues
88–90). Although binding seemed to be improved for the
E88A mutation, binding was signiﬁcantly reduced for
R89A and R90A mutants, and a double R89A/R90A
Figure 5. Solution structures of RbpA from S. coelicolor (RbpASc) and
M. tuberculosis (RbpAMt). NMR ensemble of the structure calculation
for RbpASc (orange, A) and RbpAMt (cyan, B). Ribbon representation
of the structure of RbpASc (C) and RbpAMt (D). Comparison of the
Zn-binding site of RbpASc (E) with the equivalent residues in RbpAMt
(F). Electrostatic surface potential for RbpASc (G) shown in two orien-
tations. The ﬂexible N-terminus in RbpASc is included in the orienta-
tion shown on the left and removed for clarity on the right.
Figure 6. The C-terminal region of RbpASc is necessary and sufﬁcient
for sHrdB interaction. (A) A schematic diagram indicating the regions
of RbpASc tested for interaction with sHrdB using BACTH analysis.
The RbpASc fragments and sHrdB s2–s4 were fused to the T18 and T25
domains of B. pertussis adenylate cyclase, respectively. (B) BACTH
analysis of alanine point mutations in conserved residues in the C-
terminal region of RbpASc. C, control strain containing pKT25–hrdB
and pUT18. For (A) and (B), experiments were performed in triplicate
(standard deviations indicated), and data are presented as % Miller
units relative to results obtained with the full-length wild-type
RbpASc. Control strains with pKT25–hrdB and pUT18 exhibited
<1% the activity of the full-length RbpASc interaction. (C) Growth
of S129 (rbpA), S129 containing pSETV::rbpA (WT), or equivalent
constructs with the rbpA mutations as indicated. Strains were streaked
to MS agar and photographed after 4 days incubation at 30C. (D)
In vitro transcription from the rplJ promoter in the presence of RbpASc
or RbpASc R89A/R90A mutant proteins. Multi-round in vitro tran-
scription reactions contained core RNAP (50 nM) sHrdB (250 nM),
RbpASc (250 nM or 1.25mM) and a DNA template generated by
PCR using primers listed in Supplementary Table S2. Transcript
levels were quantiﬁed by phosphorimaging, and data are presented
relative to reactions performed in the presence of sHrdB but the
absence of RbpA.
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mutant was completely defective in sHrdB binding. To test
the importance of this interaction in the function of
RbpASc, we cloned the mutant genes into the integrative
plasmid pSETV and tested for complementation of
S. coelicolor S129 (rbpA::apr). Although the introduc-
tion of wild-type rbpA and the E88A mutant (data not
shown) completely restored normal growth to S129, the
rbpA R89A/R90A mutant did not. The individual R89A
and R90A mutants also failed to completely restore
normal growth, each exhibiting a slight, but reproducible,
reduction in colony size and a delay in sporulation timing.
As the inability of the R89A/R90A double mutant to com-
plement S. coelicolor S129 might be due to protein
instability in vivo, we overexpressed the protein in E. coli
and tested whether the pure protein would stimulate tran-
scription in vitro. Using the rplJp promoter as template,
the RbpASc R89A/R90A mutant failed to stimulate tran-
scription, which suggests that a direct interaction
with sHrdB is required for the action of RbpASc.
RbpA binds to the p2 domain of the principal sigma factor
The different domains of s have distinct functions; there-
fore, to better understand the role of RbpA in transcrip-
tion initiation, we sought to localize the interaction to
individual domain(s) of sHrdB. The s2, s3 and s4 struc-
tural domains of sHrdB were predicted based on the struc-
tures of sA from Thermus sp. (11,51), and ﬁve overlapping
T25–hrdB fusions were constructed and tested for inter-
action with the rbpA–T18 fusion in BACTH analysis
(Figure 7). No interaction was detected for T25–hrdB
(s3–s4) or T25–hrdB (s4). However, all fragments that
included s2 interacted, including T25–hrdB (s2) (amino
acid residues 211–347), which comprises conserved
regions 1.2–2.4. To conﬁrm these data, each of the hrdB
constructs used in the BACTH analysis was overexpressed
with an N-terminal His6-tag, and the corresponding
proteins puriﬁed, then tested for interaction with
RbpASc using an in vitro pull-down assay (apart from
s1.1–s2, which was insoluble). The pure s
HrdB fragments
(domains s2, s2–s4, s3–s4 and s4) were mixed with
native RbpASc for 15 min and then isolated using
magnetic Ni-afﬁnity beads. RbpASc was co-isolated with
the s2 and s2–s4 fragments of s
HrdB but not with s3–s4
and s4, conﬁrming a direct and speciﬁc interaction with
the s2 domain. Using both BACTH and in vitro pull
downs, we also detected equivalent interactions between
the s2 domain of s
A and the RbpAMt (data not shown).
Furthermore, when equivalent s2 and RbpA proteins
from S. coelicolor and M. tuberculosis are co-expressed
in E. coli, with one partner His6-tagged, they co-elute as
a complex during Ni-afﬁnity chromatography (data not
shown). Taken together, these data suggest that the s2–
RbpA interaction involving the principal s factor is
conserved across the actinobacteria.
DISCUSSION
Here, we provide an explanation for why the RNA poly-
merase-binding protein RbpA stimulates transcription
from promoters that are dependent on the principal s
factor in S. coelicolor and M. tuberculosis (sHrdB and
sA), but not from promoters dependent on alternative s
factors. Although RbpASc was originally discovered as a
component of RNAP holoenzyme, and it is demonstrated
here to be present at transcription initiation complexes in
S. coelicolor, we found that RbpASc can also form a
complex with the free principal s factor. We failed to
detect RbpASc interactions with selected Group 3 (sB
and sWhiG) and Group 4 (sE and sR) s factors in S.
coelicolor, although we found that RbpASc and RbpAMt
can bind to the Group 2 s factors, sHrdA in S. coelicolor
and sB in M. tuberculosis, respectively. In S. coelicolor,
the three Group 2 s factors (sHrdA, sHrdC and sHrdD)
are collectively non-essential (52), as is sB in M. tubercu-
losis (53), which implies that the interaction with, and
activation of, the essential primary s factor underlies the
Figure 7. RbpASc binds to the s2 domain of s
HrdB. (A) A schematic
diagram indicating the four conserved regions/globular domains of
sHrdB together with BACTH interaction data between truncated
T25–sHrdB fusions and RbpASc–T18. The T25–sHrdB fusions included
the following amino acids: s1.1–s2, 1–347; s2, 211–347; s3–s4, 348–
511; s2–s4, 211–511; s4, 435–511. Control strains with pKT25 and
pUT18–rbpA exhibited <1% the activity of the s2–s4 interaction.
Experiments were performed in triplicate, and standard deviations are
indicated. (B) Interaction between His6-tagged s
HrdB fragments and
RbpASc as judged using in vitro pull-down experiments. Puriﬁed His6-
tagged sHrdB fragments (closed diamond) were mixed with RbpASc
(0.5–1 mM each) before puriﬁcation using Ni-afﬁnity magnetic
beads. Eluted proteins were separated by 4–12% Bis–Tris SDS–
PAGE and stained using Coomassie brilliant blue. RbpASc is indicated
with a black arrowhead. Closed square, unknown contaminating
protein.
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critical importance of RbpA for growth. Consistent with
this, an RbpASc mutant that failed to bind sHrdB
(RbpAR89A/R90A) did not stimulate transcription in vitro
and could not complement an S. coelicolor rbpA null
mutant. Given that sHrdB–RbpASc complexes are stably
maintained during gel ﬁltration and Ni-afﬁnity chroma-
tography, we speculate that the two proteins are able
to form an initial binary complex before the formation
of holoenzyme. One role of RbpA might, therefore,
be to act in a chaperone-like fashion to remodel s for
optimal binding to core RNAP, and thereby be an
integral component of the ‘s cycle’ in actinobacteria.
This is consistent with the observation that RbpAMt sta-
bilizes M. tuberculosis sA–RNAP holoenzyme, but it
argues for a more direct role rather than a proposed allo-
steric effect through changing the conformation of the
b lobes (25). Such a role might account for the induction
of rbpA during stress, as also proposed by others (25).
Although rbpA is continually expressed in unstressed
S. coelicolor cultures, consistent with its general import-
ance for growth (23), transcription is also induced in
response to disulphide stress, directed by the alternative
ECF s factor sR (23). InM. tuberculosis, the rbpA gene is
also induced by stress through the sR orthologue, sH (54).
The induction of rbpA might, therefore, ensure that the
increased cellular levels of free alternative s factors during
stress do not adversely affect sHrdB/sA-dependent ‘house
keeping’ gene expression, and it may also help the cell to
reset the normal state once the stress has been resolved.
Interestingly, it was recently discovered that the gene that
encodes sHrdB is also controlled by two ECF s factors:
sShbA during normal growth and sR during disulphide
stress, which would also help to maintain sHrdB activity
when stress-induced alternative s factors accumulate
in the cell (55,56). Furthermore, the Group 2 s factors
sHrdD in S. coelicolor and sB in M. tuberculosis are
induced by stress (23,57), which might also contribute
to maintaining the ‘house keeping’ duties of RNAP
during stress.
Although RbpA might play an important role in
promoting the formation of fully active sHrdB/sA holoen-
zyme, we show that RbpA is also poised to play additional
roles in the subsequent stages of transcription initiation,
such as promoter binding, and the formation and stability
of open complexes. Our ChIP–qPCR data suggest that
RbpASc is present at RNAP–promoter complexes in vivo
that have been trapped using rifampicin. As rifampicin
does not seem to inﬂuence promoter binding or open
complex formation, but rather blocks transcription when
the nascent transcript is 3 nt in length (58), RbpA might
play a role in any of the preceding stages of initiation. We
mapped the primary binding site of RbpASc to the s2
domain of sHrdB (conserved regions 1.2 and 2.1–2.4),
although we cannot rule out additional weaker or transi-
ent contacts elsewhere on the protein. The s2 domain has
several key roles in transcription initiation. As well as
forming the largest interface between s and RNAP (10),
it confers promoter speciﬁcity for the 10 element and
provides aromatic side chains that nucleate and maintain
the strand-separated state during the formation of the
open complex (6,59). Furthermore, variation in the
sequence of the discriminator element that lies between
the 10 element and the+1 transcription start point can
inﬂuence stabilizing interactions with s region 1.2, which
is exploited by factors such as ppGpp that further desta-
bilize open complexes (60). An understanding of the mech-
anism of action of RbpA is an important future goal.
In a similar manner to RbpA, the Crl protein of enteric
bacteria interacts with the s2 domain of the stationary
phase s factor sS and stimulates holoenzyme formation,
thereby contributing to the ability of sS to compete with
s70 during stationary phase or under stress, despite its
lower abundance (19,21). Crl seems to be speciﬁc for sS,
and although crl mutants were originally discovered by
their defect in curli ﬁmbriae formation, they are in fact
defective in the expression of a large subset of sS-depend-
ent genes. Nonetheless, it was found that Crl also
improved the activity of s70–RNAP when mixed with
s70 before formation of holoenzyme (18), suggesting
that Crl might also play a non-essential role in formation
of the vegetative holoenzyme. Although Crl and RbpA are
not obviously related in protein sequence, the two proteins
might play an analogous role in transcription initiation,
for example, through modulating the interaction of s
factors with RNAP and promoting the formation and
activation of certain holoenzyme complexes.
How do we reconcile our observations that RbpA inter-
acts with the s subunit with previous proposals that
RbpAMt principally interacts with the b-subunit of
RNAP (25,26)? First, it should be noted that previous
studies involved attaching chemical probes to the single
cysteine residue in RbpAMt located in the RCD, which
does not interact with s. Moreover, the cysteine is likely
to be important in proper folding of the RCD (Figure 5),
which might have caused anomalous results, although
evidence was provided that the labelled proteins were
functional. Alternatively, and perhaps more likely,
RbpA might interact with both s and b, through
distinct regions of RbpA. For example, although the s2
and the b sandwich-barrel hybrid motif are distantly
located in the holoenzyme structure, the disordered
regions of RbpA would have signiﬁcant conformational
freedom to bridge between these regions. In the structur-
ally related ribosomal protein L27, the N-terminal 1–19
residues are unstructured in its free form, but extend to a
distance of >35 A˚ from the core domain when assembled
with the ribonucleoprotein complex.
The RCD domains of S. coelicolor and M. tuberculosis
have virtually identical structures, but differ in their ability
to bind zinc. This correlates with the replacement of three
of the likely zinc ligands in RbpASc with hydrophilic
residues in RbpAMt that stabilize the domain through
a hydrogen bond network. As the zinc-coordinating
ligands are only absent from the Corynebacterium–
Mycobacterium–Nocardia (CMN) group of actino-
bacteria, but are present in certain deeply rooted
actinobacteria, such as Biﬁdobacterium sp. (61), it is
likely that zinc-free RbpA evolved soon after the emer-
gence of the CMN group. The RbpA proteins, therefore,
present an example of how the evolution of a structural
domain can contribute to a reduction in zinc require-
ments, which has also been described for alternative
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zinc-free ribosomal proteins (62,63). However, it is
unlikely that this adaptation is linked to pathogenesis
because the majority of CMN group comprises free-
living non-pathogenic strains. Although mutations of the
three zinc-coordinating cysteine residues seemed to inacti-
vate or destabilize RbpASc, the RCD domain does not
seem to be required for s interaction. BACTH analysis
and alanine scanning mutagenesis of RbpASc revealed that
the C-terminal predicted helical region was required for
this interaction, and that the highly conserved amino acid
residues R89 and R90 play a critical role, although it is not
yet clear whether they contact s directly, or whether their
mutation disrupts the overall conformation of this region.
Although the C-terminal region is predicted to be helical,
NMR analysis of the full-length RbpA proteins from both
S. coelicolor andM. tuberculosis suggested that this region
in each protein is unstructured, and despite extensive
attempts to prevent it, it is readily proteolysed to the
RCD during storage. The binding to s, therefore, likely
promotes folding of the RbpA C-terminal region, thereby
stabilizing the complex. Clearly, future structural charac-
terization of RbpA either in a binary complex with s or in
higher order complexes with RNAP will be highly
valuable in understanding further mechanistic aspects of
the function of this protein. This is likely to be of particu-
lar importance in the development of new approaches to
target the process of transcription in M. tuberculosis and
other pathogenic actinobacteria.
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